{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:13:15Z","timestamp":1794453195786,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Postgraduate Scientific Research Innovation Program Project","award":["KYCX25_3277"],"award-info":[{"award-number":["KYCX25_3277"]}]},{"name":"the New Technology project of Affiliated Hospital of Xuzhou Medical University","award":["2020301018"],"award-info":[{"award-number":["2020301018"]}]},{"name":"Xuzhou Medical leading Talent training Project","award":["XWRCHT20210038"],"award-info":[{"award-number":["XWRCHT20210038"]}]},{"name":"The Open Project of Key Laboratory of Higher Education Institutions in Jiangsu Province","award":["XZSYSKF2023019"],"award-info":[{"award-number":["XZSYSKF2023019"]}]},{"name":"Xuzhou Basic Research Program","award":["KC22042"],"award-info":[{"award-number":["KC22042"]}]},{"name":"Paired Assistance Scientific Research Project by The Affiliated Hospital of Xuzhou Medical University","award":["SHJDBF2024104"],"award-info":[{"award-number":["SHJDBF2024104"]}]},{"name":"The High-Level Hospital Construction Project of Jiangsu Province","award":["LCZX202403"],"award-info":[{"award-number":["LCZX202403"]}]},{"name":"Science and technology development fund of Affiliated Hospital of Xuzhou Medical University","award":["XYFY2020038"],"award-info":[{"award-number":["XYFY2020038"]}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["BK20211054"],"award-info":[{"award-number":["BK20211054"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04370-w","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:16:27Z","timestamp":1776402987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibiting lactylation for efficient treatment of renal fibrosis through targeting nanomedicine of renal lactate accumulation in obstructed kidney"],"prefix":"10.1186","volume":"24","author":[{"given":"Pingshi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"4370_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet Elsevier. 2013;382:260\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(13)60687-X.","journal-title":"Lancet Elsevier"},{"key":"4370_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pharmthera.2010.05.006","volume":"128","author":"JM L\u00f3pez-Novoa","year":"2010","unstructured":"L\u00f3pez-Novoa JM, Mart\u00ednez-Salgado C, Rodr\u00edguez-Pe\u00f1a AB, Hern\u00e1ndez FJL. Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives. Pharmacol Ther. 2010;128:61\u201381. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.05.006.","journal-title":"Pharmacol Ther"},{"key":"4370_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2019.05.032","volume":"76","author":"C Yang","year":"2020","unstructured":"Yang C, Wang H, Zhao X, Matsushita K, Coresh J, Zhang L, et al. CKD in China: Evolving Spectrum and Public Health Implications. Am J Kidney Dis Elsevier. 2020;76:258\u201364. https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.032.","journal-title":"Am J Kidney Dis Elsevier"},{"key":"4370_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Sig Transduct Target Ther. Nat Publishing Group. 2023;8:129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Nat Publishing Group"},{"key":"4370_CR5","doi-asserted-by":"publisher","first-page":"19660","DOI":"10.1038\/s41598-023-46146-4","volume":"13","author":"C Gaupp","year":"2023","unstructured":"Gaupp C, Schmid B, Tripal P, Edwards A, Daniel C, Zimmermann S, et al. Reconfiguration and loss of peritubular capillaries in chronic kidney disease. Sci Rep Nat Publishing Group. 2023;13:19660. https:\/\/doi.org\/10.1038\/s41598-023-46146-4.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"4370_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","volume":"21","author":"L Abbad","year":"2025","unstructured":"Abbad L, Esteve E, Chatziantoniou C. Advances and challenges in kidney fibrosis therapeutics. Nat Rev Nephrol Nat Publishing Group. 2025;21:314\u201329. https:\/\/doi.org\/10.1038\/s41581-025-00934-5.","journal-title":"Nat Rev Nephrol Nat Publishing Group"},{"key":"4370_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1186\/s12967-025-06748-0","volume":"23","author":"H Liang","year":"2025","unstructured":"Liang H, Xu L, Yang Y. Lactate and lactylation: novel perspectives on fibrosis pathogenesis and therapeutic directions. J Transl Med. 2025;23:705. https:\/\/doi.org\/10.1186\/s12967-025-06748-0.","journal-title":"J Transl Med"},{"key":"4370_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ymthe.2024.12.053","volume":"33","author":"X Li","year":"2025","unstructured":"Li X, Chen J, Li J, Zhang Y, Xia J, Du H, et al. ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD. Molecular Therapy. Elsevier. 2025;33:805\u201322. https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.053.","journal-title":"Elsevier"},{"key":"4370_CR9","doi-asserted-by":"publisher","first-page":"2469746","DOI":"10.1080\/0886022X.2025.2469746","volume":"47","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Guo L. Lactate metabolism and lactylation in kidney diseases: insights into mechanisms and therapeutic opportunities. Ren Fail Taylor Francis. 2025;47:2469746. https:\/\/doi.org\/10.1080\/0886022X.2025.2469746.","journal-title":"Ren Fail Taylor Francis"},{"key":"4370_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40364-025-00849-0","volume":"13","author":"S Xiao","year":"2025","unstructured":"Xiao S, Zhang S, Sun K, Huang Q, Li Q, Hu C. Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies. Biomark Res. 2025;13:134. https:\/\/doi.org\/10.1186\/s40364-025-00849-0.","journal-title":"Biomark Res"},{"key":"4370_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1530578","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu D, Yin S, Gao Y, Li X, Wu G. Metabolism and epigenetics in cancer: toward personalized treatment. Front Endocrinol [Internet] Front. 2025. https:\/\/doi.org\/10.3389\/fendo.2025.1530578. [cited 2026 Feb 14];16.","journal-title":"Front Endocrinol [Internet] Front"},{"key":"4370_CR12","doi-asserted-by":"publisher","unstructured":"Fang N, Zhang N, Jiang X, Yan S, Wang Z, Gao Q et al. PFKM-Driven Lactate Overproduction Promotes Atrial Fibrillation via Triggering Cardiac Fibroblasts Histone Lactylation. Adv Sci (Weinh). Weinheim, Baden-Wurttemberg, Germany; 2025;12:e00963. https:\/\/doi.org\/10.1002\/advs.202500963","DOI":"10.1002\/advs.202500963"},{"key":"4370_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jcm5070063","volume":"5","author":"A Moustakas","year":"2016","unstructured":"Moustakas A, Heldin C-H. Mechanisms of TGF\u03b2-Induced Epithelial\u2013Mesenchymal Transition. Journal of Clinical Medicine. Multidisciplinary Digit Publishing Inst. 2016;5:63. https:\/\/doi.org\/10.3390\/jcm5070063.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR14","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/jcp.25797","volume":"232","author":"T Chen","year":"2017","unstructured":"Chen T, You Y, Jiang H, Wang ZZ. Epithelial\u2013mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232:3261\u201372. https:\/\/doi.org\/10.1002\/jcp.25797.","journal-title":"J Cell Physiol"},{"key":"4370_CR15","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s42003-022-03994-6","volume":"5","author":"A Bertrand-Chapel","year":"2022","unstructured":"Bertrand-Chapel A, Caligaris C, Fenouil T, Savary C, Aires S, Martel S, et al. SMAD2\/3 mediate oncogenic effects of TGF-\u03b2 in the absence of SMAD4. Commun Biol Nat Publishing Group. 2022;5:1068. https:\/\/doi.org\/10.1038\/s42003-022-03994-6.","journal-title":"Commun Biol Nat Publishing Group"},{"key":"4370_CR16","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, et al. Induction of renal fibrotic genes by TGF-\u03b21 requires EGFR activation, p53 and reactive oxygen species. Cell Signal. 2013;25:2198\u2013209. https:\/\/doi.org\/10.1016\/j.cellsig.2013.07.007.","journal-title":"Cell Signal"},{"key":"4370_CR17","doi-asserted-by":"publisher","first-page":"l5873","DOI":"10.1136\/bmj.l5873","volume":"367","author":"AK Bello","year":"2019","unstructured":"Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ Br Med J Publishing Group. 2019;367:l5873. https:\/\/doi.org\/10.1136\/bmj.l5873.","journal-title":"BMJ Br Med J Publishing Group"},{"key":"4370_CR18","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1038\/s41598-025-86496-9","volume":"15","author":"L Yang","year":"2025","unstructured":"Yang L, Si P, Kuerban T, Guo L, Zhan S, Zuhaer Y, et al. UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-\u03b2\/SMAD signaling pathway. Sci Rep Nat Publishing Group. 2025;15:3346. https:\/\/doi.org\/10.1038\/s41598-025-86496-9.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"4370_CR19","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138. https:\/\/doi.org\/10.1172\/JCI39104.","journal-title":"J Clin Invest"},{"key":"4370_CR20","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 2018;7:6124\u201336. https:\/\/doi.org\/10.1002\/cam4.1820.","journal-title":"Cancer Med"},{"key":"4370_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","volume":"56","author":"JL Fisher","year":"2009","unstructured":"Fisher JL. The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator. Neuropharmacology. 2009;56:190\u20137. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.004.","journal-title":"Neuropharmacology"},{"key":"4370_CR22","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","volume":"15","author":"F Khan","year":"2024","unstructured":"Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu W-H, et al. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nat Commun Nat Publishing Group. 2024;15:1987. https:\/\/doi.org\/10.1038\/s41467-024-46193-z.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"4370_CR23","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/pharmaceutics15061641","volume":"15","author":"S Meirinho","year":"2023","unstructured":"Meirinho S, Rodrigues M, Santos AO, Falc\u00e3o A, Alves G. Intranasal Microemulsion as an Innovative and Promising Alternative to the Oral Route in Improving Stiripentol Brain Targeting. Pharmaceutics. Multidisciplinary Digit Publishing Inst. 2023;15:1641. https:\/\/doi.org\/10.3390\/pharmaceutics15061641.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR24","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.2147\/IJN.S87471","volume":"10","author":"R Lu","year":"2015","unstructured":"Lu R, Liu S, Wang Q, Li X. Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement. IJN Dove Press. 2015;10:4937\u201346. https:\/\/doi.org\/10.2147\/IJN.S87471.","journal-title":"IJN Dove Press"},{"key":"4370_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jpha.2020.11.005","volume":"11","author":"S Meirinho","year":"2021","unstructured":"Meirinho S, Rodrigues M, Fortuna A, Falc\u00e3o A, Alves G. Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review. J Pharm Anal. 2021;11:405\u201321. https:\/\/doi.org\/10.1016\/j.jpha.2020.11.005.","journal-title":"J Pharm Anal"},{"key":"4370_CR26","doi-asserted-by":"publisher","first-page":"106601","DOI":"10.1016\/j.reactfunctpolym.2025.106601","volume":"219","author":"F Liang","year":"2026","unstructured":"Liang F, Li J, Feng Y, Zhou Y, Cao L, Omoding D, et al. Advances and prospects in Alzheimer\u2019s disease diagnosis and treatment using MOFs and COFs: Mechanism and AI-assisted strategies. Reactive Funct Polym. 2026;219:106601. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2025.106601.","journal-title":"Reactive Funct Polym"},{"key":"4370_CR27","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.reactfunctpolym.2025.106520","volume":"218","author":"D Ma","year":"2026","unstructured":"Ma D, Liang T, Zheng J, Chen G, Ye Y, Nezamzadeh-Ejhieh A, et al. MOF-based platforms on diabetic disease: Advanced and prospect of effective diagnosing and therapy. Reactive Funct Polym. 2026;218:106520. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2025.106520.","journal-title":"Reactive Funct Polym"},{"key":"4370_CR28","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori Y, Ajay AK, Chang J-H, Mou S, Zhao H, Kishi S, et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metabolism Elsevier. 2021;33:1042\u2013e10617. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.004.","journal-title":"Cell Metabolism Elsevier"},{"key":"4370_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrneph.2015.40","volume":"11","author":"EF Carney","year":"2015","unstructured":"Carney EF. Proximal tubule cells modulate inflammation after renal injury. Nat Rev Nephrol Nat Publishing Group. 2015;11:254\u2013254. https:\/\/doi.org\/10.1038\/nrneph.2015.40.","journal-title":"Nat Rev Nephrol Nat Publishing Group"},{"key":"4370_CR30","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules Multidisciplinary Digit Publishing Inst. 2022;27:1372. https:\/\/doi.org\/10.3390\/molecules27041372.","journal-title":"Molecules Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1021\/acs.molpharmaceut.0c01182","volume":"18","author":"J Zhou","year":"2021","unstructured":"Zhou J, Li R, Zhang J, Liu Q, Wu T, Tang Q, et al. Targeting Interstitial Myofibroblast-Expressed Integrin \u03b1v\u03b23 Alleviates Renal Fibrosis. Mol Pharm Am Chem Soc. 2021;18:1373\u201385. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01182.","journal-title":"Mol Pharm Am Chem Soc"},{"key":"4370_CR32","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1681\/ASN.2020111561","volume":"32","author":"T-T Tang","year":"2021","unstructured":"Tang T-T, Wang B, Li Z-L, Wen Y, Feng S-T, Wu M, et al. Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI. J Am Soc Nephrol. 2021;32:2467. https:\/\/doi.org\/10.1681\/ASN.2020111561.","journal-title":"J Am Soc Nephrol"},{"key":"4370_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","volume":"320","author":"R Li","year":"2020","unstructured":"Li R, Li Y, Zhang J, Liu Q, Wu T, Zhou J, et al. Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity. J Controlled Release. 2020;320:32\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.017.","journal-title":"J Controlled Release"},{"key":"4370_CR34","doi-asserted-by":"publisher","first-page":"9034","DOI":"10.1038\/s41467-025-64096-5","volume":"16","author":"G Wu","year":"2025","unstructured":"Wu G, Yang C, Huang Y, Liu B, Zhai H, Cao Z, et al. Histone lactylation promotes rheumatoid arthritis progression by increasing NFATc2 expression and the production of anti-lactylated histone autoantibodies. Nat Commun. 2025;16:9034. https:\/\/doi.org\/10.1038\/s41467-025-64096-5.","journal-title":"Nat Commun"},{"key":"4370_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","volume":"106","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-\u03baB family activation. Kidney Int Elsevier. 2024;106:226\u201340. https:\/\/doi.org\/10.1016\/j.kint.2024.04.016.","journal-title":"Kidney Int Elsevier"},{"key":"4370_CR36","doi-asserted-by":"publisher","first-page":"2500595","DOI":"10.1002\/adhm.202500595","volume":"14","author":"Q Guo","year":"2025","unstructured":"Guo Q, Lu X, Zhang Y, Huang Z, Liu S, Qiao L, et al. A Nanoplatform Targeting Cascade Pathways for Enhanced Triptolide Delivery in Acute Kidney Injury Therapy. Adv Healthc Mater. 2025;14:2500595. https:\/\/doi.org\/10.1002\/adhm.202500595.","journal-title":"Adv Healthc Mater"},{"key":"4370_CR37","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.drudis.2025.104420","volume":"30","author":"X Yan","year":"2025","unstructured":"Yan X, Zhang G, Wei H, Yang L, Jiang X. Lysine lactylation: Regulatory mechanisms, role in health and disease, and its therapeutic potential. Drug Discovery Today. 2025;30:104420. https:\/\/doi.org\/10.1016\/j.drudis.2025.104420.","journal-title":"Drug Discovery Today"},{"key":"4370_CR38","doi-asserted-by":"publisher","first-page":"14019","DOI":"10.3390\/ijms241814019","volume":"24","author":"A Niculae","year":"2023","unstructured":"Niculae A, Gherghina M-E, Peride I, Tiglis M, Nechita A-M, Checherita IA. Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2023;24:14019. https:\/\/doi.org\/10.3390\/ijms241814019.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrneph.2015.215","volume":"12","author":"D Zhou","year":"2016","unstructured":"Zhou D, Liu Y. Understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol Nat Publishing Group. 2016;12:68\u201370. https:\/\/doi.org\/10.1038\/nrneph.2015.215.","journal-title":"Nat Rev Nephrol Nat Publishing Group"},{"key":"4370_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/jpm14121141","volume":"14","author":"C Delrue","year":"2024","unstructured":"Delrue C, Eisenga MF, Delanghe JR, Speeckaert MM. Personalized Antifibrotic Therapy in CKD Progression. Journal of Personalized Medicine. Multidisciplinary Digit Publishing Inst. 2024;14:1141. https:\/\/doi.org\/10.3390\/jpm14121141.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13020-024-01004-x","volume":"19","author":"W Wang","year":"2024","unstructured":"Wang W, Dai R, Cheng M, Chen Y, Gao Y, Hong X, et al. Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play? Chin Med. 2024;19:148. https:\/\/doi.org\/10.1186\/s13020-024-01004-x.","journal-title":"Chin Med"},{"key":"4370_CR42","doi-asserted-by":"publisher","first-page":"2587326","DOI":"10.1080\/07853890.2025.2587326","volume":"57","author":"X Wei","year":"2025","unstructured":"Wei X, Long M, Yu J, Du Y. The lactate-lactylation axis in renal fibrosis: potential mechanisms in diabetic kidney disease. Annals Med Taylor Francis. 2025;57:2587326. https:\/\/doi.org\/10.1080\/07853890.2025.2587326.","journal-title":"Annals Med Taylor Francis"},{"key":"4370_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13148-025-01947-4","volume":"17","author":"S Yang","year":"2025","unstructured":"Yang S, Ye Z, Zhao S, Cheng F. Lactylation modifications in urological diseases: molecular mechanisms and biological implications. Clin Epigenet. 2025;17:139. https:\/\/doi.org\/10.1186\/s13148-025-01947-4.","journal-title":"Clin Epigenet"},{"key":"4370_CR44","doi-asserted-by":"publisher","first-page":"103246","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol. 2024;75:103246. https:\/\/doi.org\/10.1016\/j.redox.2024.103246.","journal-title":"Redox Biol"},{"key":"4370_CR45","doi-asserted-by":"publisher","first-page":"156324","DOI":"10.1016\/j.phymed.2024.156324","volume":"136","author":"T Xiang","year":"2025","unstructured":"Xiang T, Wang X, Huang S, Zhou K, Fei S, Zhou B, et al. Inhibition of PKM2 by shikonin impedes TGF-\u03b21 expression by repressing histone lactylation to alleviate renal fibrosis. Phytomedicine. 2025;136:156324. https:\/\/doi.org\/10.1016\/j.phymed.2024.156324.","journal-title":"Phytomedicine"},{"key":"4370_CR46","doi-asserted-by":"publisher","first-page":"2403305","DOI":"10.1002\/advs.202403305","volume":"11","author":"F Zeng","year":"2024","unstructured":"Zeng F, Qin Y, Nijiati S, Liu Y, Ye J, Shen H, et al. Ultrasmall Nanodots with Dual Anti-Ferropototic Effect for Acute Kidney Injury Therapy. Adv Sci. 2024;11:2403305. https:\/\/doi.org\/10.1002\/advs.202403305.","journal-title":"Adv Sci"},{"key":"4370_CR47","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.3390\/molecules29112584","volume":"29","author":"CO Egwu","year":"2024","unstructured":"Egwu CO, Aloke C, Onwe KT, Umoke CI, Nwafor J, Eyo RA, et al. Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine. Molecules Multidisciplinary Digit Publishing Inst. 2024;29:2584. https:\/\/doi.org\/10.3390\/molecules29112584.","journal-title":"Molecules Multidisciplinary Digit Publishing Inst"},{"key":"4370_CR48","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.2147\/IJN.S520967","volume":"20","author":"Y Montano-Peguero","year":"2025","unstructured":"Montano-Peguero Y, Verdejo HE, Riquelme JA, Kogan MJ, Lavandero S. Nanomedicine for Diagnosis and Treatment of Cardiac Fibrosis. IJN Dove Press. 2025;20:9723\u201346. https:\/\/doi.org\/10.2147\/IJN.S520967.","journal-title":"IJN Dove Press"},{"key":"4370_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4103\/1735-5362.213979","volume":"12","author":"S Shaker","year":"2017","unstructured":"Shaker S, Gardouh AR, Ghorab MM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharm Sci. 2017;12:346. https:\/\/doi.org\/10.4103\/1735-5362.213979.","journal-title":"Res Pharm Sci"},{"key":"4370_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.colsurfb.2013.07.066","volume":"112","author":"A Laouini","year":"2013","unstructured":"Laouini A, Charcosset C, Fessi H, Holdich RG, Vladisavljevi\u0107 GT. Preparation of liposomes: A novel application of microengineered membranes\u2013From laboratory scale to large scale. Colloids Surf B. 2013;112:272\u20138. https:\/\/doi.org\/10.1016\/j.colsurfb.2013.07.066.","journal-title":"Colloids Surf B"},{"key":"4370_CR51","doi-asserted-by":"publisher","first-page":"22508","DOI":"10.1021\/acsnano.3c05998","volume":"17","author":"L Luo","year":"2023","unstructured":"Luo L, Wang S, Hu Y, Wang L, Jiang X, Zhang J, et al. Precisely Regulating M2 Subtype Macrophages for Renal Fibrosis Resolution. ACS Nano Am Chem Soc. 2023;17:22508\u201326. https:\/\/doi.org\/10.1021\/acsnano.3c05998.","journal-title":"ACS Nano Am Chem Soc"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04370-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04370-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04370-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:00Z","timestamp":1781650560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04370-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4370"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04370-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were carried out in accordance with the relevant regulations of the Jiangsu Province Laboratory Animal Management Measures and had been approved by the Experimental Animal Ethics Committee of Xuzhou Medical University (number 202311T006). All the authors complied with the relevant ethical regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"572"}}